Top News

• FDA Biologics Chief Vinay Prasad to Step Down in April
• Guidance Urges Comprehensive Responses to Inspection Findings
• FDA Official Criticizes Advisory Committee Experts
• Public Trusts FDA Career Scientists Over Agency Leadership
• FDA Cites Documentation Lapses at Maiva Pharma
• FDA Flags Expanded Recall of Reprocessed Cardiac Catheters
• Breakthrough Status for Hemabs Bleeding Disorder Therapy
• Petition Asks FDA to Investigate Mayo Robotic Mastectomy